Controversies in testosterone supplementation therapy

Asian Journal of Andrology

Volumn 17, Issue 2, 2015, Pages 175-176

  Khera, Mohit ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ANDROGEN THERAPY; DIABETES MELLITUS; HUMAN; HYPOPHYSIS GONAD SYSTEM; LOWER URINARY TRACT SYMPTOM; MALE; METABOLIC SYNDROME X; OBESITY; PROSTATE CANCER; REVIEW; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE SUPPLEMENTATION THERAPY; AGED; AGING; CARDIOVASCULAR DISEASE; COMPLICATION; DEFICIENCY; EUNUCHISM; HORMONE SUBSTITUTION; LOWER URINARY TRACT SYMPTOMS; METABOLISM; OSTEOPOROSIS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; EUNUCHISM; HORMONE REPLACEMENT THERAPY; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; OSTEOPOROSIS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; TESTOSTERONE;

EID: 84924738820     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.148728     Document Type: Review

References (20)

1. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 2004; 89: 503-10.
2. Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 2009; 30: 477-94.
3. Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl 2009; 30: 23-32.
4. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res 2009; 21: 1-8.
5. Lazarou S, Reyes-Vallejo L, Morgentaler A. Wide variability in laboratory reference values for serum testosterone. J Sex Med 2006; 3: 1085-9.
6. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86: 724-31.
7. Fraser LA, Morrison D, Morley-Forster P, Paul TL, Tokmakejian S, et al. Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 2009; 117: 38-43.
8. Sun YT, Irby DC, Robertson DM, de Kretser DM. The effects of exogenously administered testosterone on spermatogenesis in intact and hypophysectomized rats. Endocrinology 1989; 125: 1000-10.
9. Khera M, Crawford D, Morales A, Salonia A, Morgentaler A. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014; 65: 115-23.
10. Shigehara K, Sugimoto K, Konaka H, Iijima M, Fukushima M, et al. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study. Aging Male 2011; 14: 53-8.
11. Kalinchenko S, Vishnevskiy EL, Koval AN, Mskhalaya GJ, Saad F. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study. Aging Male 2008; 11: 57-61.
12. Finkle WD, Greenland S, Ridgeway GK, Adams JL, Frasco MA, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One 2014; 9: e85805.
13. Vigen R, O'Donnell CI, Barón AE, Grunwald GK, Maddox TM, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013; 310: 1829-36.
14. McBride JA, Carson CC, Coward RM. Diagnosis and management of testosterone deficiency. Asian J Androl 2015; 10.4103/1008-682X.143317.
15. Hwang K, Miner M. Controversies in testosterone replacement therapy: testosterone and cardiovascular disease. Asian J Androl 2015; 10.4103/1008-682X.146968.
16. Cunningham GR. Testosterone and metabolic syndrome. Asian J Androl 2015; 10.4103/1008-682X.148068.
17. Ramasamy R, Armstrong JM, Lipshultz LI. Preserving fertility in the hypogonadal patient: an update. Asian J Androl 2015; 10.4103/1008-682X.140081.
18. McCullough A. Alternatives to Testosterone replacement: testosterone restoration (TRES). Asian J Androl 2015; 10.4103/1008-682X.143736.
19. Morgentaler A, Conners WP. Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations. Asian J Androl 2015; 10.4103/1008-682X.148067.
20. Jarvis TR, Chughtai B, Kaplan SA. Testosterone and benign prostatic hyperplasia. Asian J Androl 2015; 10.4103/1008-682X.140966.